The addition of any anti-diabetic medication, such as SYMLIN, to an existing regimen of one or more anti-diabetic medications (e.g., sulfonylurea), or other medications that can increase the risk of hypoglycemia may necessitate further insulin dose adjustments and particularly close monitoring of blood glucose
It reads pathway-level variants such as FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline metabolic biology, context that holds regardless of which telehealth service prescribes the compound
Another major concern that came up in many queries was "glp-1 patches side effects." While I personally didn't experience specific GLP-1 related side effects (because, again, it's unlikely much active ingredient was absorbed), I've seen countless reports and 'FDA warnings' about potential issues
A response to a critical review of the BMAA hypothesis
You should also choose supplements that are third-party tested to ensure they're free from contaminants and meet strict standards